Document is current
Any future updates will be listed below
-
Authors
Fróes, Renata de Sá Brito https://orcid.org/0000-0003-3256-4698
Andrade, Adriana Ribas https://orcid.org/0000-0001-6012-2155
Faria, Mikaell Alexandre Gouvea https://orcid.org/0000-0003-4121-0306
de Souza, Heitor Siffert Pereira https://orcid.org/0000-0002-3647-7324
Parra, Rogério Serafim https://orcid.org/0000-0002-5566-9284
Zaltman, Cyrla https://orcid.org/0000-0002-5236-6501
dos Santos, Carlos Henrique Marques https://orcid.org/0000-0002-1181-7329
Bafutto, Mauro https://orcid.org/0000-0001-5585-3957
Quaresma, Abel Botelho https://orcid.org/0000-0002-3985-7402
Santana, Genoile Oliveira https://orcid.org/0000-0001-5936-9791
Luporini, Rafael Luís https://orcid.org/0000-0003-2757-8104
de Lima Junior, Sérgio Figueiredo https://orcid.org/0000-0002-1250-2628
Miszputen, Sender Jankiel https://orcid.org/0000-0003-4487-5004
de Souza, Mardem Machado https://orcid.org/0000-0003-0520-7425
Herrerias, Giedre Soares Prates https://orcid.org/0000-0002-8159-4618
Junior, Roberto Luiz Kaiser https://orcid.org/0000-0003-1952-1255
do Nascimento, Catiane Rios https://orcid.org/0009-0003-3053-1662
Féres, Omar https://orcid.org/0000-0003-3593-0526
de Barros, Jaqueline Ribeiro https://orcid.org/0000-0003-1451-8794
Sassaki, Ligia Yukie https://orcid.org/0000-0002-7319-8906
Saad-Hossne, Rogerio https://orcid.org/0000-0002-8166-0304
-
Funding
Funding for this research was provided by:
Brazilian Organization for Crohn's Disease and Colitis - GEDIIB
- License Information
-
More Information
Article History
Received: 8 October 2023
Accepted: 12 February 2024
First Online: 21 February 2024
Competing interests
: Renata de Sá Brito Fróes—Received lecture fee[s] from AbbVie, Janssen, Takeda, Ferring and Pfizer; is advisory committee member for Janssen and Takeda; Adriana Ribas Andrade—Received lecture fee[s] from AbbVie, Janssen; Mikaell Alexandre Gouvea Faria—Received lecture fee[s] from AbbVie, Janssen, Takeda, Nestlé, advisory committee member for Janssen; Rogério Serafim Parra—Received lecture fee[s] from AbbVie, Janssen, Takeda, and Pfizer; is advisory committee member for Janssen and AbbVie; Cyrla Zaltman—Received lecture fee[s] from Janssen, Takeda, Celltrion, Pfizer; Carlos Henrique Marques dos Santos—Received lecture fee[s] from AbbVie, Janssen, Takeda; Mauro Bafutto—Received lecture fee[s] from AbbVie, Janssen, Takeda; Abel Botelho Quaresma—Received lecture fee[s] from AbbVie, Janssen; Genoile Oliveira Santana—Received lecture fee[s] from AbbVie, Janssen, Takeda, Ferring and Pfizer; is advisory committee member for Janssen; Rafael Luís Luporini—Received lecture fee[s] from AbbVie, Janssen, Takeda; Mardem Machado de Souza—Received lecture fee[s] from AbbVie, Janssen, Takeda; Ligia Yukie Sassaki—Received lecture fee[s] from Janssen; Rogerio Saad-Hossne—Received lecture fee[s] and advisory committee member for AbbVie, Takeda, Janssen, Pfizer, Fresenius and Amgen. Heitor Siffert Pereira de Souza, Sérgio Figueiredo de Lima Junior, Sender Jankiel Miszputen, Giedre Soares Prates Herrerias, Roberto Luiz Kaiser Junior, Catiane Rios do Nascimento, Omar Féres, Jaqueline Ribeiro de Barros—No potential conflict of interest to disclose.
